Literature DB >> 30051485

Endocannabinoid regulation of homeostatic feeding and stress-induced alterations in food intake in male rats.

Martin A Sticht1,2,3,4,5, David J Lau1,2,3,4, Catherine M Keenan1,5, Jean-Baptiste Cavin1,5, Maria Morena1,2,3,4, Venkata Kiran Vemuri6, Alexandros Makriyannis6, Benjamin F Cravatt7, Keith A Sharkey1,5, Matthew N Hill1,2,3,4.   

Abstract

BACKGROUND AND
PURPOSE: Stress is known to reduce food intake. Many aspects of the stress response and feeding are regulated by the endocannabinoid system, but the roles of anandamide (AEA) and 2-arachidonoyl glycerol (2-AG) in stress-induced anorexia are unclear. EXPERIMENTAL APPROACH: Effects of acute restraint stress on endocannabinoids were investigated in male Sprague-Dawley rats. Systemic and central pharmacological inhibition of fatty acid amide hydrolase (FAAH) or monoacylglycerol lipase (MAGL) was used to assess the effects of elevated AEA and 2-AG on homeostatic feeding and on food consumption after stress. Animals were pretreated with the FAAH inhibitor, PF-04457845, or the MAGL inhibitor, MJN110, before 2 h acute restraint stress or 2 h homecage period without food. KEY
RESULTS: Restraint stress decreased hypothalamic and circulating AEA, with no effect in the gastrointestinal tract, while 2-AG content in the jejunum (but not duodenum) was reduced. PF-04457845 (30 μg), given i.c.v., attenuated stress-induced anorexia via CB1 receptors, but reduced homeostatic feeding in unstressed animals through an unknown mechanism. On the other hand, systemic administration of MJN110 (10 mg·kg-1 ) reduced feeding, regardless of stress or feeding status and inhibited basal intestinal transit in unstressed rats. The ability of MAGL inhibition to reduce feeding in combination with stress was independent of CB1 receptor signalling in the gut as the peripherally restricted CB1 receptor antagonist, AM6545 did not block this effect. CONCLUSIONS AND IMPLICATIONS: Our data reveal diverse roles for 2-AG and AEA in homeostatic feeding and changes in energy intake following stress. LINKED ARTICLES: This article is part of a themed section on 8th European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30051485      PMCID: PMC6487552          DOI: 10.1111/bph.14453

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  72 in total

1.  Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling.

Authors:  Nathan K Evanson; Jeffrey G Tasker; Matthew N Hill; Cecilia J Hillard; James P Herman
Journal:  Endocrinology       Date:  2010-08-11       Impact factor: 4.736

2.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Influence of intracerebroventricular or intraperitoneal administration of cannabinoid receptor agonist (WIN 55,212-2) and inverse agonist (AM 251) on the regulation of food intake and hypothalamic serotonin levels.

Authors:  Ikram Merroun; Mohammed Errami; Hanaa Hoddah; Gloria Urbano; Jesús M Porres; Pilar Aranda; Juan Llopis; María López-Jurado
Journal:  Br J Nutr       Date:  2009-02-27       Impact factor: 3.718

4.  Effects of chronic stress on food intake in rats: influence of stressor intensity and duration of daily exposure.

Authors:  O Martí; J Martí; A Armario
Journal:  Physiol Behav       Date:  1994-04

Review 5.  The link between stress and feeding behaviour.

Authors:  Jayanthi Maniam; Margaret J Morris
Journal:  Neuropharmacology       Date:  2012-04-24       Impact factor: 5.250

6.  Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response.

Authors:  Matthew N Hill; Ryan J McLaughlin; Bin Pan; Megan L Fitzgerald; Christopher J Roberts; Tiffany T-Y Lee; Ilia N Karatsoreos; Ken Mackie; Victor Viau; Virginia M Pickel; Bruce S McEwen; Qing-song Liu; Boris B Gorzalka; Cecilia J Hillard
Journal:  J Neurosci       Date:  2011-07-20       Impact factor: 6.167

7.  Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype.

Authors:  Luis A Natividad; Matthew W Buczynski; Melissa A Herman; Dean Kirson; Christopher S Oleata; Cristina Irimia; Ilham Polis; Roberto Ciccocioppo; Marisa Roberto; Loren H Parsons
Journal:  Biol Psychiatry       Date:  2017-01-13       Impact factor: 13.382

8.  Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function.

Authors:  J Megan Gray; Christopher D Wilson; Tiffany T Y Lee; Quentin J Pittman; Jan M Deussing; Cecilia J Hillard; Bruce S McEwen; Jay Schulkin; Ilia N Karatsoreos; Sachin Patel; Matthew N Hill
Journal:  Psychoneuroendocrinology       Date:  2016-01-11       Impact factor: 4.905

9.  Endocannabinoids in the Gut.

Authors:  Nicholas V DiPatrizio
Journal:  Cannabis Cannabinoid Res       Date:  2016-02-24

10.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors.

Authors:  Stephen Ph Alexander; John A Cidlowski; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

View more
  9 in total

1.  Cannabinoids and their actions: An update.

Authors:  Stephen P H Alexander; Francisco Molina-Holgado
Journal:  Br J Pharmacol       Date:  2019-05       Impact factor: 8.739

2.  Endocannabinoid regulation of homeostatic feeding and stress-induced alterations in food intake in male rats.

Authors:  Martin A Sticht; David J Lau; Catherine M Keenan; Jean-Baptiste Cavin; Maria Morena; Venkata Kiran Vemuri; Alexandros Makriyannis; Benjamin F Cravatt; Keith A Sharkey; Matthew N Hill
Journal:  Br J Pharmacol       Date:  2018-08-22       Impact factor: 8.739

Review 3.  On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.

Authors:  Karen Jaqueline Paredes-Ruiz; Karla Chavira-Ramos; Mario Orozco-Morales; Cimen Karasu; Alexey A Tinkov; Michael Aschner; Abel Santamaría; Ana Laura Colín-González
Journal:  Neurotox Res       Date:  2021-11-06       Impact factor: 3.911

Review 4.  Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.

Authors:  Stuart M Brierley; Beverley Greenwood-Van Meerveld; Giovanni Sarnelli; Keith A Sharkey; Martin Storr; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-27       Impact factor: 73.082

5.  The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors.

Authors:  Malte Feja; Martin P K Leigh; Ajay N Baindur; Justin J McGraw; Ken T Wakabayashi; Benjamin F Cravatt; Caroline E Bass
Journal:  Neuropharmacology       Date:  2019-10-17       Impact factor: 5.250

6.  Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase.

Authors:  Haley A Vecchiarelli; Maria Morena; Catherine M Keenan; Vincent Chiang; Kaitlyn Tan; Min Qiao; Kira Leitl; Alessia Santori; Quentin J Pittman; Keith A Sharkey; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2021-01-15       Impact factor: 7.853

7.  Sex-dependent effects of endocannabinoid modulation of conditioned fear extinction in rats.

Authors:  Maria Morena; Andrei S Nastase; Alessia Santori; Benjamin F Cravatt; Rebecca M Shansky; Matthew N Hill
Journal:  Br J Pharmacol       Date:  2021-01-13       Impact factor: 9.473

8.  Inhibition of MAGL activates the Keap1/Nrf2 pathway to attenuate glucocorticoid-induced osteonecrosis of the femoral head.

Authors:  Ning Yang; Houyi Sun; Yi Xue; Weicheng Zhang; Hongzhi Wang; Huaqiang Tao; Xiaolong Liang; Meng Li; Yaozeng Xu; Liang Chen; Liang Zhang; Lixin Huang; Dechun Geng
Journal:  Clin Transl Med       Date:  2021-06

Review 9.  Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease.

Authors:  Matteo Tardelli
Journal:  World J Gastroenterol       Date:  2020-07-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.